𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety

✍ Scribed by John J. Sramek; Edyta J. Frackiewicz; Neal R. Cutlet


Book ID
117322167
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
594 KB
Volume
19
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Meta-analysis of the safety and tolerabi
✍ John J. Sramek; Walter W. Hong; Suha Hamid; Barbara Nape; Neal R. Cutler πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 1 views

Buspirone is an azapirone with 5-HT 1A partial agonist activity which has demonstrated efficacy in the treatment of generalized anxiety disorder, commonly referred to as persistent anxiety. In this meta-analysis report, safety results from two studies comparing buspirone 15 mg twice daily (BID) with